Teladoc Health, Inc.

NYSE:TDOC Lagerbericht

Marktkapitalisierung: US$1.7b

Teladoc Health Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Teladoc Health wird ein jährliches Gewinn- und Umsatzwachstum von 53.3% bzw. 3.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 52% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -4.5% betragen.

Wichtige Informationen

53.3%

Wachstumsrate der Gewinne

52.0%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum26.9%
Wachstumsrate der Einnahmen3.6%
Zukünftige Eigenkapitalrendite-4.5%
Analystenabdeckung

Good

Zuletzt aktualisiert26 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?

Jun 04
Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?

Teladoc: Stock Likely To Be Range Bound Until Guidance Is Revised Upwards

May 31

Teladoc: Huge Execution Problem

Apr 27

Teladoc: Improving Business Trends (Rating Upgrade)

Apr 17

Teladoc: Management Has A Lot To Prove To Gain Investor Confidence

Mar 25

Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Mar 10
Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues

Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation

Feb 21

Teladoc Health: Weight Management Rescue

Jan 21

Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

Jan 15
Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Dec 12
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Q3: Getting Stronger (Rating Upgrade)

Nov 29

Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Nov 22
Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price

Teladoc Was Obliterated

Oct 25

Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Oct 11
Is Teladoc Health (NYSE:TDOC) A Risky Investment?

Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)

Oct 02

Teladoc Stock: A Hold Amid New Covid Wave

Sep 14

Teladoc's Technical Decline Hints At A Buying Opportunity

Aug 28

Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Aug 18
Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?

Buy Teladoc: AI Will Likely Spur Healthcare Deflation

Aug 16

Teladoc's Future: Virtual Healthcare, AI, And Valuation

Jul 28

Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo

Jul 21

The Big Trends: New Frontiers in Healthcare

Jul 13
The Big Trends: New Frontiers in Healthcare

When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Jul 10
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health: Likely To Remain Out Of Favor

Jun 26

Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Jun 25
Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors

Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

May 25
Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt

Teladoc: BetterHelp Segment Margins Are Key

May 23

Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

May 06
Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?

Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Mar 10
Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?

Teladoc Health Non-GAAP EPS of -$0.23 misses by $0.04, revenue of $637.7M beats by $4.33M

Feb 22

Is Teladoc Health (NYSE:TDOC) Using Too Much Debt?

Feb 01
Is Teladoc Health (NYSE:TDOC) Using Too Much Debt?

Teladoc's Stock Is Showing Signs Of Life

Jan 30

Teladoc: Unrealistic Assumptions Required To Buy

Jan 09

Teladoc: A Bargain If It Ever Reaches GAAP Profitability

Jan 02

An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 45% Undervalued

Dec 23
An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 45% Undervalued

Why did Teladoc Health stock fall today? Continued pressure for telehealth providers

Dec 22

Teladoc: Death By A Thousand Paper Cuts

Dec 17

What Is Teladoc Health, Inc.'s (NYSE:TDOC) Share Price Doing?

Nov 16
What Is Teladoc Health, Inc.'s (NYSE:TDOC) Share Price Doing?

Amazon Clinic seen putting pressure on telehealth providers Him & Hers Health, Teladoc

Nov 15

Teladoc Health GAAP EPS of -$0.45 beats by $0.12, revenue of $611.4M beats by $2.41M

Oct 26

Teladoc Health: Focus On Management Guidance And Takeover Potential

Oct 20

Teladoc: Cathie Wood Does It Again

Oct 11

Teladoc: The White Flag

Sep 27

Teladoc: Yes, Patient Investors Are Rewarded Again - Buy This Pullback

Sep 20

Gewinn- und Umsatzwachstumsprognosen

NYSE:TDOC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20262,867-8332446412
12/31/20252,755-11128142225
12/31/20242,659-17720634725
3/31/20242,619-233200346N/A
12/31/20232,602-220194350N/A
9/30/20232,580-4,002112285N/A
6/30/20232,531-4,01864243N/A
3/31/20232,471-7,05447234N/A
12/31/20222,407-13,66017189N/A
9/30/20222,323-9,86065207N/A
6/30/20222,234-9,871107221N/A
3/31/20222,144-6,90499180N/A
12/31/20212,033-429130194N/A
9/30/20211,862-812-54-4N/A
6/30/20211,629-763-92-49N/A
3/31/20211,367-655-102-65N/A
12/31/20201,094-485-80-54N/A
9/30/2020867-1105980N/A
6/30/2020716-954661N/A
3/31/2020606-981931N/A
12/31/2019553-991930N/A
9/30/2019520-105414N/A
6/30/2019493-108211N/A
3/31/2019457-103-81N/A
12/31/2018418-97-13-5N/A
9/30/2018372-117-22-15N/A
6/30/2018330-125-44-37N/A
3/31/2018280-115-42-36N/A
12/31/2017233-107N/A-34N/A
9/30/2017194-77N/A-35N/A
6/30/2017157-75N/A-38N/A
3/31/2017139-75N/A-47N/A
12/31/2016123-74N/A-52N/A
9/30/2016108-75N/A-57N/A
6/30/201696-58N/A-59N/A
3/31/201688-61N/A-54N/A
12/31/201577-58N/A-47N/A
9/30/201568-50N/A-39N/A
6/30/201559-42N/A-24N/A
3/31/201551-29N/A-19N/A
12/31/201444-20N/A-11N/A
12/31/201320-10N/A-6N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: TDOC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: TDOC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: TDOC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: TDOCDie Einnahmen des Unternehmens (3.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: TDOCDie Einnahmen des Unternehmens (3.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: TDOC wird voraussichtlich in 3 Jahren unrentabel sein.

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y